AU6049099A - Human chorionic gonadotropin vaccines - Google Patents
Human chorionic gonadotropin vaccinesInfo
- Publication number
- AU6049099A AU6049099A AU60490/99A AU6049099A AU6049099A AU 6049099 A AU6049099 A AU 6049099A AU 60490/99 A AU60490/99 A AU 60490/99A AU 6049099 A AU6049099 A AU 6049099A AU 6049099 A AU6049099 A AU 6049099A
- Authority
- AU
- Australia
- Prior art keywords
- vaccines
- chorionic gonadotropin
- human chorionic
- gonadotropin
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000011022 Chorionic Gonadotropin Human genes 0.000 title 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 title 1
- 229940084986 human chorionic gonadotropin Drugs 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10076698P | 1998-09-17 | 1998-09-17 | |
US60100766 | 1998-09-17 | ||
PCT/US1999/021591 WO2000015253A1 (en) | 1998-09-17 | 1999-09-16 | Human chorionic gonadotropin vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6049099A true AU6049099A (en) | 2000-04-03 |
Family
ID=22281429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU60490/99A Abandoned AU6049099A (en) | 1998-09-17 | 1999-09-16 | Human chorionic gonadotropin vaccines |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1113814A1 (en) |
CN (1) | CN1326359A (en) |
AU (1) | AU6049099A (en) |
WO (1) | WO2000015253A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201204751D0 (en) * | 2012-03-19 | 2012-05-02 | Isis Innovation | Immune modulation |
EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5823847B2 (en) * | 1981-02-06 | 1983-05-18 | 株式会社 林原生物化学研究所 | Method for producing anti-human protein antibodies |
US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
PT789590E (en) * | 1994-09-23 | 2002-12-31 | Zonagen Inc | IMMUNOPOTATION INDUCED BY QUITOSAN |
-
1999
- 1999-09-16 EP EP99969033A patent/EP1113814A1/en not_active Withdrawn
- 1999-09-16 CN CN99813381A patent/CN1326359A/en active Pending
- 1999-09-16 AU AU60490/99A patent/AU6049099A/en not_active Abandoned
- 1999-09-16 WO PCT/US1999/021591 patent/WO2000015253A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1326359A (en) | 2001-12-12 |
EP1113814A1 (en) | 2001-07-11 |
WO2000015253A1 (en) | 2000-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9623898A (en) | Vaccines | |
AU3792497A (en) | Methods of promoting hematopoiesis using derivatives of human chorionic gonadotropin | |
AU2001236148A1 (en) | Polyorganosilsesquioxane and process for preparing the same | |
TW493433U (en) | Tampax | |
EP1100011A3 (en) | Scriptor and interpreter | |
AU5020400A (en) | Heteroaryloxypyrimidine insecticides and acaricides | |
EP1083926A4 (en) | Vaccine | |
IL140984A0 (en) | Fsh and fsh variant formulations, products and methods | |
AU3684895A (en) | Use of human chorionic gonadotropin as an immune-potentiating agent | |
AU2660900A (en) | 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents | |
AU3159499A (en) | Antigen preparation and use | |
AU3472799A (en) | Dermatological formulations and methods | |
AU3388400A (en) | Human glycosylation enzymes | |
AU1608201A (en) | Human zven proteins | |
AU2841801A (en) | Triazolotriazinones and the use thereof | |
AU5977700A (en) | Vaccines | |
GB9822714D0 (en) | Vaccines | |
GB0027072D0 (en) | Vaccine | |
CZ20011896A3 (en) | Immunogenic preparation and antibody | |
AU6158700A (en) | Vaccine | |
AU3357700A (en) | Phenoxypyrimidine insecticides and acaricides | |
EP1023083A4 (en) | Veterinary vaccines | |
AU6049099A (en) | Human chorionic gonadotropin vaccines | |
AU2227999A (en) | Human ependymin | |
AU4456800A (en) | Human hac3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |